US health regulators loosen rules for newborn genetic tests
What happened
US health regulators are making it easier to approve devices that detect genetic variations in newborns. This means manufacturers can bring these tests to market faster, potentially giving parents more options.
Why it matters
Genetic tests for newborns previously faced the highest level of regulatory scrutiny, which slowed down their availability. This change moves them into a category with specific, but less burdensome, requirements. Companies can now develop and sell these tests more quickly, which could increase their use in diagnosing conditions in infants.
The signal
Watch how many new postnatal chromosomal copy number variation detection systems get approved in the next 12-24 months compared to previous years.